van Vollenhoven RF, Zamani O, Wallace DJ. et al. Belimumab, a BLyS-specific inhibitor, reduces disease activity and severe flares in seropositive SLE patients: BLISS-76 study. Ann Rheum Dis 2010; 69: 74.
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.